Business Context and Reporting Period
Company: AEye, Inc. (LIDR)
Filing Type: Form 8-K (Current Report)
Date of Report: January 3, 2025
Event Date: January 2, 2025
AEye, Inc., a Delaware corporation, entered into a Securities Purchase Agreement with an institutional investor to secure financing through a senior unsecured convertible promissory note and warrants.
Key Financial Metrics and Transaction Details
| Metric | Value |
|---|---|
| Principal Amount of Note | $3,240,000 |
| Purchase Price Paid | $3,000,013.20 |
| Original Issue Discount (OID) | 7.4% |
| Interest Rate | 7.0% per annum |
| Note Term | 18 months |
| Conversion Price | $2.22 per share |
| Warrant Shares | 805,263 shares |
| Warrant Exercise Price | $2.22 per share |
| Warrant Exercisability | Commences 6 months and 1 day after issuance; expires 4 years thereafter |
Material Changes and Repayment Structure
The filing details a new debt obligation not present in prior periods. The repayment structure includes:
- Installment Payments: Commencing 90 days after closing, the Company must pay monthly installments. Each installment generally consists of one-fifteenth of the initial principal amount plus accrued interest and fees.
- Payment Method: The Company may elect to pay installments in shares of Common Stock if certain equity conditions are met. The conversion price for these payments is the lower of the Conversion Price ($2.22) or 90% of the VWAP (subject to a $0.30 floor). Otherwise, payments are made in cash.
- Exchange Cap: Issuance of shares is restricted by NASDAQ Listing Rule 5635(d). If the cap is reached after June 15, 2025, and the Company cannot issue shares upon conversion, it must make a cash payment in lieu of shares.
Outlook, Risks, and Contingencies
Registration Rights: The Company agreed to register the resale of shares issuable upon conversion of the Note and exercise of the Warrant under the Securities Act of 1933.
Risks and Covenants: The Note contains customary covenants, events of default, and triggering events that could require immediate repayment of outstanding obligations.
Regulatory Compliance: The securities were issued in reliance on exemptions under Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D. The filing does not constitute an offer to sell securities in jurisdictions where such an offer would be unlawful.
Investor Verification Checklist
- Verify the closing conditions of the Purchase Agreement to confirm the $3,000,013.20 funding has been received.
- Monitor the Company's ability to satisfy equity conditions required for paying installments in stock versus cash.
- Review the impact of the "Exchange Cap" on potential dilution and cash outflows if the cap is triggered after June 15, 2025.
- Assess the Company's liquidity position given the monthly principal repayment obligation starting 90 days post-closing.
- Confirm the status of the Registration Rights Agreement to ensure future liquidity for the investor.